Observe Medical Asa (OBSRV) - Total Liabilities
Based on the latest financial reports, Observe Medical Asa (OBSRV) has total liabilities worth Nkr71.21 Million NOK (≈ $7.49 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check OBSRV financial resilience to evaluate the company's liquid asset resilience ratio.
Observe Medical Asa - Total Liabilities Trend (2016–2025)
This chart illustrates how Observe Medical Asa's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Observe Medical Asa asset portfolio.
Observe Medical Asa Competitors by Total Liabilities
The table below lists competitors of Observe Medical Asa ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Taruga Minerals Ltd
AU:TAR
|
Australia | AU$269.24K |
|
Miwon Chemical
KO:134380
|
Korea | ₩45.89 Billion |
|
Khind Holdings Bhd
KLSE:7062
|
Malaysia | RM126.37 Million |
|
GigaMedia Limited
F:GIFN
|
Germany | €3.82 Million |
|
Scienture Holdings, Inc.
NASDAQ:SCNX
|
USA | $23.63 Million |
|
Toleranzia AB
ST:TOL
|
Sweden | Skr9.54 Million |
|
YXT.COM GROUP HOLDING LIMITED American Depository Shares
NASDAQ:YXT
|
USA | $339.61 Million |
|
Minbos Resources Ltd
AU:MNB
|
Australia | AU$2.11 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Observe Medical Asa's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Observe Medical Asa balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.26 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.70 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Observe Medical Asa's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Observe Medical Asa (2016–2025)
The table below shows the annual total liabilities of Observe Medical Asa from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Nkr71.21 Million ≈ $7.49 Million |
-42.71% |
| 2024-12-31 | Nkr124.30 Million ≈ $13.08 Million |
-6.36% |
| 2023-12-31 | Nkr132.74 Million ≈ $13.97 Million |
+71.27% |
| 2022-12-31 | Nkr77.51 Million ≈ $8.16 Million |
-9.73% |
| 2021-12-31 | Nkr85.86 Million ≈ $9.04 Million |
+27.42% |
| 2020-12-31 | Nkr67.39 Million ≈ $7.09 Million |
+65.20% |
| 2019-12-31 | Nkr40.79 Million ≈ $4.29 Million |
-2.90% |
| 2018-12-31 | Nkr42.01 Million ≈ $4.42 Million |
-20.20% |
| 2017-12-31 | Nkr52.64 Million ≈ $5.54 Million |
-3.13% |
| 2016-12-31 | Nkr54.34 Million ≈ $5.72 Million |
-- |
About Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a dig… Read more